Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood.

Proitsi P, Lee SH, Lunnon K, Keohane A, Powell J, Troakes C, Al-Sarraj S, Furney S, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Hodges A; AddNeuroMed Consortium.

Neurobiol Aging. 2014 Feb;35(2):279-90. doi: 10.1016/j.neurobiolaging.2013.08.002. Epub 2013 Sep 21.

PMID:
24064185
2.

MS4A6A genotypes are associated with the atrophy rates of Alzheimer's disease related brain structures.

Ma J, Zhang W, Tan L, Wang HF, Wan Y, Sun FR, Tan CC, Yu JT, Tan L, Alzheimer's Disease Neuroimaging Initiative.

Oncotarget. 2016 Sep 13;7(37):58779-58788. doi: 10.18632/oncotarget.9563.

3.

Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease.

Rodríguez-Rodríguez E, Sánchez-Juan P, Vázquez-Higuera JL, Mateo I, Pozueta A, Berciano J, Cervantes S, Alcolea D, Martínez-Lage P, Clarimón J, Lleó A, Pastor P, Combarros O.

J Neural Transm (Vienna). 2013 May;120(5):807-12. doi: 10.1007/s00702-012-0920-x. Epub 2012 Nov 20.

PMID:
23180304
4.

The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer's disease.

Deng YL, Liu LH, Wang Y, Tang HD, Ren RJ, Xu W, Ma JF, Wang LL, Zhuang JP, Wang G, Chen SD.

Hum Genet. 2012 Jul;131(7):1245-9. doi: 10.1007/s00439-012-1154-6. Epub 2012 Mar 1.

PMID:
22382309
5.

Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease.

Carrasquillo MM, Crook JE, Pedraza O, Thomas CS, Pankratz VS, Allen M, Nguyen T, Malphrus KG, Ma L, Bisceglio GD, Roberts RO, Lucas JA, Smith GE, Ivnik RJ, Machulda MM, Graff-Radford NR, Petersen RC, Younkin SG, Ertekin-Taner N.

Neurobiol Aging. 2015 Jan;36(1):60-7. doi: 10.1016/j.neurobiolaging.2014.07.042. Epub 2014 Aug 4.

6.

Plasma clusterin levels and the rs11136000 genotype in individuals with mild cognitive impairment and Alzheimer's disease.

Mullan GM, McEneny J, Fuchs M, McMaster C, Todd S, McGuinness B, Henry M, Passmore AP, Young IS, Johnston JA.

Curr Alzheimer Res. 2013 Nov;10(9):973-8.

PMID:
24117116
7.

Common variants in ABCA7 and MS4A6A are associated with cortical and hippocampal atrophy.

Ramirez LM, Goukasian N, Porat S, Hwang KS, Eastman JA, Hurtz S, Wang B, Vang N, Sears R, Klein E, Coppola G, Apostolova LG.

Neurobiol Aging. 2016 Mar;39:82-9. doi: 10.1016/j.neurobiolaging.2015.10.037. Epub 2015 Nov 6.

PMID:
26923404
8.

Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.

Martiskainen H, Viswanathan J, Nykänen NP, Kurki M, Helisalmi S, Natunen T, Sarajärvi T, Kurkinen KM, Pursiheimo JP, Rauramaa T, Alafuzoff I, Jääskeläinen JE, Leinonen V, Soininen H, Haapasalo A, Huttunen HJ, Hiltunen M.

Neurobiol Aging. 2015 Feb;36(2):1221.e15-28. doi: 10.1016/j.neurobiolaging.2014.09.003. Epub 2014 Sep 6.

PMID:
25281018
9.

A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer's disease.

Lacher SE, Alazizi A, Wang X, Bell DA, Pique-Regi R, Luca F, Slattery M.

Redox Biol. 2018 Apr;14:686-693. doi: 10.1016/j.redox.2017.10.018. Epub 2017 Oct 27.

10.

Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment.

Chico L, Simoncini C, Lo Gerfo A, Rocchi A, Petrozzi L, Carlesi C, Volpi L, Tognoni G, Siciliano G, Bonuccelli U.

Free Radic Res. 2013 Aug;47(8):569-76. doi: 10.3109/10715762.2013.804622. Epub 2013 Jun 19.

PMID:
23668794
11.

Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.

Kerr DS, Stella F, Radanovic M, Aprahamian I, Bertollucci PH, Forlenza OV.

Bipolar Disord. 2016 Feb;18(1):71-7. doi: 10.1111/bdi.12367. Epub 2016 Feb 15.

PMID:
26877211
12.

Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains.

Karch CM, Jeng AT, Nowotny P, Cady J, Cruchaga C, Goate AM.

PLoS One. 2012;7(11):e50976. doi: 10.1371/journal.pone.0050976. Epub 2012 Nov 30.

13.

ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects.

Manzine PR, Marcello E, Borroni B, Kamphuis W, Hol E, Padovani A, Nascimento CC, de Godoy Bueno P, Assis Carvalho Vale F, Iost Pavarini SC, Di Luca M, Cominetti MR.

Biomarkers. 2015;20(3):196-201. doi: 10.3109/1354750X.2015.1062554. Epub 2015 Aug 4.

PMID:
26220620
14.

Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease.

Berchtold NC, Sabbagh MN, Beach TG, Kim RC, Cribbs DH, Cotman CW.

Neurobiol Aging. 2014 Sep;35(9):1961-72. doi: 10.1016/j.neurobiolaging.2014.03.031. Epub 2014 Apr 2.

15.

Screening of Early and Late Onset Alzheimer's Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy.

Ferrari R, Ferrara M, Alinani A, Sutton RB, Famà F, Picco A, Rodriguez G, Nobili F, Momeni P.

Curr Alzheimer Res. 2015;12(8):802-12.

PMID:
26159191
16.

Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood.

Lunnon K, Ibrahim Z, Proitsi P, Lourdusamy A, Newhouse S, Sattlecker M, Furney S, Saleem M, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Coppola G, Geschwind D, Simmons A, Lovestone S, Dobson R, Hodges A; AddNeuroMed Consortium.

J Alzheimers Dis. 2012;30(3):685-710. doi: 10.3233/JAD-2012-111592.

PMID:
22466004
17.

PIN-1 promoter polymorphisms in mild cognitive impairment and susceptibility to Alzheimer's disease: a preliminary report.

Arosio B, Segat L, Milanese M, Galimberti L, Calabresi C, Zanetti M, Trabattoni D, Annoni G, Crovella S, Vergani C.

Aging Clin Exp Res. 2007 Oct;19(5):406-9.

PMID:
18007120
18.

The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study.

Brainerd CJ, Reyna VF, Petersen RC, Smith GE, Kenney AE, Gross CJ, Taub ES, Plassman BL, Fisher GG.

Neuropsychology. 2013 Jan;27(1):86-94. doi: 10.1037/a0030855.

19.

Association of GWAS-linked loci with late-onset Alzheimer's disease in a northern Han Chinese population.

Tan L, Yu JT, Zhang W, Wu ZC, Zhang Q, Liu QY, Wang W, Wang HF, Ma XY, Cui WZ.

Alzheimers Dement. 2013 Sep;9(5):546-53. doi: 10.1016/j.jalz.2012.08.007. Epub 2012 Dec 8.

PMID:
23232270
20.

HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study.

Leduc V, De Beaumont L, Théroux L, Dea D, Aisen P, Petersen RC; Alzheimer's Disease Neuroimaging Initiative, Dufour R, Poirier J.

Mol Psychiatry. 2015 Jul;20(7):867-73. doi: 10.1038/mp.2014.81. Epub 2014 Jul 15.

Supplemental Content

Support Center